In conclusion, this study demonstrates a protective role of FBXW7 in the development and progression of NAFLD by attenuating inflammation and consequent insulin resistance, which is associated with the suppression of HMGB1-mediated innate immune signaling. This evidence concerns the gene HMGB1 and metabolic dysfunction-associated steatotic liver disease.